Proton therapy and liver transplant for bile duct cancer
Part of Cancer clinical trials.
This trial combines proton beam therapy with a liver transplant to treat a specific type of bile duct cancer (hilar cholangiocarcinoma). It aims to improve outcomes by using radiation before surgery to help make the transplant more successful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 17 years old or older.
- You need to be well enough to undergo a liver transplant (determined by your medical team).
- You must have a type of bile duct cancer called hilar cholangiocarcinoma, confirmed by biopsy.
- The cancer must not have spread to other parts of your body, including lymph nodes.
- You must have a history of primary sclerosing cholangitis (PSC) — a condition that causes bile duct inflammation — at least initially.
- You must not have had radiation therapy to your upper abdomen before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of immunotherapy (tislelizumab), radiation, and chemotherapy before surgery for people with bile duct cancer that is hard to remove. The goal is to shrink the tumor enough to allow successful surgery.
This trial tests a combination of radiation therapy (PULSAR), immunotherapy, and chemotherapy for advanced bile duct cancer. It aims to see if this approach can shrink tumors and improve survival.
This trial tests a combination of immunotherapy (PD-L1 antibody) with chemotherapy and radiation before a liver transplant for patients with advanced hilar bile duct cancer. It aims to shrink the tumor and improve transplant outcomes.
This trial studies liver transplantation to treat a specific bile duct cancer (perihilar cholangiocarcinoma) that cannot be removed by surgery. It aims to see if a transplant can help when standard chemotherapy has kept the cancer stable.
This trial tests if a liver transplant can help people with a certain type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. Before the transplant, you would receive radiation therapy (SIRT) and chemotherapy to shrink the tumor.
This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.